NCT02004080

Brief Summary

CREACTIVE is a large-scale observational cohort study concerning Traumatic Brain Injury (TBI) care in the ICU setting

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Longer than P75 for all trials

Geographic Reach
1 country

20 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 6, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

2.2 years

First QC Date

December 3, 2013

Last Update Submit

March 15, 2022

Conditions

Keywords

TBIICUComparative Effectiveness Research

Outcome Measures

Primary Outcomes (2)

  • Glasgow Outcome Scale Extendend (GOSe)

    6 months

  • Quality of life in Brain Injury Overall Scale (QOLIBRI-OS)

    6 months

Secondary Outcomes (1)

  • Mortality

    6 months

Study Arms (1)

TBI admitted to ICU

Intensive Care treatment

Other: Intensive Care treatment

Interventions

intensive care treatment

TBI admitted to ICU

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

TBI patients admitted to ICU for specific care

You may qualify if:

  • All patients admitted to the participating ICUs with a diagnosis of traumatic brain injury, regardless of their severity,will be recruited.

You may not qualify if:

  • Absence of Informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Ospedale Regionale della Valle d'Aosta

Aosta, Aosta Valley, 11100, Italy

Location

A.O. Universitaria Policlinico "Riuniti"

Foggia, Apulia, 71100, Italy

Location

Ospedale Santa Maria di Loreto

Napoli, Campania, 80100, Italy

Location

Ospedale Maggiore

Bologna, Emilia Romagan, 40131, Italy

Location

AUSL della Romagna, Ospedale Bufalini

Cesena, Emilia-Romagna, 47023, Italy

Location

Ospedale San Camillo Forlanini

Rome, Lazio, 00152, Italy

Location

Presidio Ospedliero di Cremon

Cremona, Lombardy, 26100, Italy

Location

Niguarda Cà Granda

Milan, Lombardy, 20162, Italy

Location

Ospedale A. Manzoni

Lecco, Lombradia, 23900, Italy

Location

SS. Antonio e Biagio e C. Arrigo

Alessandria, Piedmont, 15100, Italy

Location

Ospedale Edoardo Agnelli

Pinerolo, Piedmont, 10064, Italy

Location

CTO Maria Adelaide

Turin, Piedmont, 10126, Italy

Location

Ospedale Giovanni Paolo II

Olbia, Sardinia, 07026, Italy

Location

AO Villa Sofia - Cervello

Palermo, Sicily, 90100, Italy

Location

Ospedale San Salvatore

Pesaro, The Marches, 61100, Italy

Location

Ospedale del Mugello

Borgo San Lorenzo, Tuscany, 50032, Italy

Location

AO Universitaria Careggi

Florence, Tuscany, 50134, Italy

Location

Ospedale di S. Chiara

Pisa, Tuscany, 56100, Italy

Location

Ospedale di Santa Chiara

Pisa, Tuscany, 56100, Italy

Location

Ospedale Santa Maria della Misericordia

Perugia, Umbria, 06100, Italy

Location

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples day 1 and 5 from ICU admission.

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Guido Bertolini, MD

    Istituto Di Ricerche Farmacologiche Mario Negri

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2013

First Posted

December 6, 2013

Study Start

October 1, 2013

Primary Completion

December 1, 2015

Study Completion

March 1, 2019

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations